CERT

Certara (CERT)

About Certara (CERT)

Certara, Inc. engages in the provision of software and technology-enabled services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017 and is headquartered in Radnor, PA.

Details

Daily high

$8.28

Daily low

$8.06

Price at open

$8.13

52 Week High

$13.88

52 Week Low

$4.45

Market cap

1.3B

Dividend yield

0.00%

Volume

431,250

Avg. volume

4.1M

P/E ratio

-85.31

Certara News